In February 2026, HHS announced that approximately 14 previously restricted peptides are expected to return to Category 1 compounding status, a regulatory development that supports the continued availability of compounded peptides at clinics like Perfect B
Figure 3
They are not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease
Before purchasing, consider asking for: Batch-specific COAs HPLC chromatograms LC-MS results Batch numbers Quality-control documentation Transparent suppliers should be able to provide supporting information for their products
By engaging amylin receptor biology and influencing appetite and glucose regulation, Cagrilintide provides a versatile platform for research into metabolic balance, weight biology, and systemic regulation in laboratory models
Another important flag: We currently dont have any safety data about the use of sermorelin in people with a history of cancer